Abstract:BackgroundPrevious studies have presented skeletal muscle loss was associated with diabetes mellitus (DM) and non-alcoholic fatty liver disease (NAFLD). However, whether the presence of NAFLD could influence the association between skeletal muscle mass and DM was still unknown. The aim of the present study was to investigate the relationship of skeletal muscle mass with diabetes in Chinese middle-aged and older community population, and whether the association could be effected by NAFLD.MethodsA cross-sectional study of 5,626 residents aged 45 and above in Changfeng community in Shanghai were conducted. Skeletal muscle mass (SMM) was detected by dual-energy X ray absorption (DXA) and calculated as ASM% [appendicular skeletal muscle mass (ASM) (kg) /body weight*100%]. Liver fat content (LFC) was measured using a quantitative ultrasound method. Multivariate logistic regression analyses were conducted to investigate the association between ASM% quartiles with DM.ResultsWith ASM% decreasing, fasting blood glucose (FBG), 2-hour postprandial blood glucose (2hBG) and Homeostasis model assessment for insulin resistance (HOMA-IR) as well as LFC increased in both genders, and the prevalence of diabetes and NAFLD also increased. Spearman analysis showed ASM% was negatively correlated with FBG, 2hBG and LFC. Stepwise logistic regression analysis showed after multiple adjustments, ASM% quartile was negatively associated with the risk of diabetes only in male, but not in female. Subgroup analysis found the ASM% quartiles remained negatively correlated with the risk of diabetes in male non-NAFLD population, but not in NAFLD population. When stratified by LFC quartiles, the results was similar. After multivariate adjustments, low ASM% was negatively correlated with the risk of diabetes only in the first and second LFC quartile in male, and the association remained insignificant in each LFC quartile in female.ConclusionsSkeletal muscle mass was negatively associated with the risk of diabetes in male population but not in female. The presence of NAFLD weakened this association. The results suggested stratified management of diabetes should be considered according to skeletal muscle mass and the presence of NAFLD.

Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.

Sarcopenia is Associated with the Presence of Nonalcoholic Fatty Liver Disease in Zhejiang Province, China: a Cross-Sectional Observational Study

Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease

[The Association Between Body Mass Index and Non-Alcoholic Fatty Liver Disease].

Association between non-alcoholic fatty liver disease and risk of sarcopenia: a systematic review and meta-analysis

Skeletal muscle mass indexes and nonalcoholic fatty liver disease in Chinese elders

Increased Risk of Low Bone Mineral Density in Patients with Non-Alcoholic Fatty Liver Disease: A Cohort Study

Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population‐Based Study

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults

Skeletal Muscle Loss is Associated with Diabetes in Middle-Aged and Older Chinese Men Without Non-Alcoholic Fatty Liver Disease

Presence of Sarcopenia Identifies a Special Group of Lean NAFLD in Middle-Aged and Older People.

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

The PNPLA3 Rs738409 C>G Variant Influences the Association Between Low Skeletal Muscle Mass and NAFLD: the Shanghai Changfeng Study

Strong association between sarcopenic obesity and non-alcoholic fatty liver disease: An observational study with ISarcoPRM algorithm

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

Skeletal Muscle Loss Was Associated with the Risk of Diabetes in Non Non-Alcoholic Fatty Liver Disease Chinese Male Middle-Aged and Elderly Population, the Shanghai Changfeng Study

Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods

The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study

Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice